Global Circulating Tumor Cell (CTC) Diagnostics Industry

Global Circulating Tumor Cell (CTC) Diagnostics Market to Reach $19 Billion by 2027. Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$6.

New York, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Circulating Tumor Cell (CTC) Diagnostics Industry" - https://www.reportlinker.com/p04778754/?utm_source=GNW
2 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. CTC Enrichment Methods, one of the segments analyzed in the report, is projected to record a 17.8% CAGR and reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTC Detection Methods segment is readjusted to a revised 17% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 16.6% CAGR

The Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 16.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.4% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

CTC Analysis Segment to Record 16.3% CAGR

In the global CTC Analysis segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.3 Billion by the year 2027.We bring years of research experience to this 18th edition of our report. The 186-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• ApoCell, Inc.

• Biocep Ltd.

• Biocept, Inc.

• Biofluidica Microtechnologies LLC

• Celltraffix Inc.

• Clearbridge Biomedics

• Creatv Microtech, Inc.

• Cynvenio Biosystems, Inc.

• Fluxion Biosciences, Inc.

• Ikonisys, Inc.

• IVDiagnostics, Inc.

• Janssen Diagnostics LLC

• QIAGEN Hannover GmbH

• Rarecells Sas

• Screencell

• Stemcell Technologies, Inc.

Read the full report: https://www.reportlinker.com/p04778754/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Market Outlook
Recent Market Activity
Clinical Relevance of CTCs
CTC Detection - Real-Time ’Liquid Biopsy’ Scores Over Surgical
Biopsy
Major Challenges in CTC Diagnostics
Need for CTC Enrichment and Popular Methods
CTC Enrichment Techniques
Select Available CTC Detection Technologies
Select CTC Isolation Systems - A Brief Comparison
CTC Identification - Various Approaches
CTC Identification Approaches
List of mRNA Markers for RT-PCR-based Detection of CTCs by
Tumor Type
CellSearch System? - The First FDA Approved Automated
Enrichment/Isolation Technique
Rising Incidence of Cancer - An Opportunity Indicator
Cancer Prone Sites based on Age
Global Competitor Market Shares
Circulating Tumor Cell (CTC) Diagnostics Competitor Market
Share Scenario Worldwide (in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
ApoCell, Inc. (US)
Biocep Ltd. (Israel)
Biocept, Inc. (US)
Biofluidica Microtechnologies LLC (US)
Celltraffix Inc. (US)
Clearbridge Biomedics (Singapore)
Creatv Microtech, Inc. (US)
Cynvenio Biosystems, Inc. (US)
Epic Biosciences Inc. (US)
Fluxion Biosciences, Inc. (US)
Ikonisys, Inc. (US)
IVDiagnostics, Inc. (US)
Janssen Diagnostics LLC (US)
QIAGEN Hannover GmbH (Germany)
RARECELLS SAS (Italy)
ScreenCell (France)
STEMCELL Technologies, Inc. (Canada)

3. MARKET TRENDS & DRIVERS
Liquid Biopsy - the New Buzzword in Healthcare
Select Companies Active in Cancer Liquid Biopsy
CTCs for Personalized Cancer Treatment
Microfluidic Chip-based Technologies - A Promising Avenue for
Cancer Diagnosis
CTC Microdevices Hog the Limelight
Increasing Research Reveal Further Complexities to CTC
Composition and Behavior
EpCAM Glycoprotein - Insufficient for CTC Detection
New Isolation Techniques Show Promise in Detecting EpCAM-
Negative CTCs
Physical Property-based Enrichment Technologies Lose Fizz
Evidence in Favor CTC Heterogeneity Gains Strength
CTC Clusters Raise Research Interest
Detection of EMTs Gains Precedence in the Backdrop of Recent
Research Findings
Limitations of CTC Technology for Point-of-Care Testing
CTC Technologies Offer an Edge over Imaging Tests for Breast
Cancer Prognosis
Limited Biomarkers Utilized In CTC Diagnostics - A Threat to
Market Growth?
Select Research Findings in Recent Years
Microfluidic Device with Micro-Hall Sensors Detect CTCs with
Higher Sensitivity and Specificity
NBiomics Makes its Contribution to CTC Diagnosis
Researchers at University of Michigan Develop Revolutionary
Capture CTCs Method
Dean Flow Fractionation to Overcome Limitations Associated with
Conventional Biomarker Analysis
Gold Nanoparticles Help in the Detection of CTCs

4. GLOBAL MARKET PERSPECTIVE
Table 1: Circulating Tumor Cell (CTC) Diagnostics Global Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 2: Circulating Tumor Cell (CTC) Diagnostics Global
Retrospective Market Scenario in US$ Million by Region/Country:
2012-2019

Table 3: Circulating Tumor Cell (CTC) Diagnostics Market Share
Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: CTC Enrichment Methods (Technology) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 5: CTC Enrichment Methods (Technology) Historic Market
Analysis by Region/Country in US$ Million: 2012 to 2019

Table 6: CTC Enrichment Methods (Technology) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027

Table 7: CTC Detection Methods (Technology) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027

Table 8: CTC Detection Methods (Technology) Historic Market
Perspective by Region/Country in US$ Million: 2012 to 2019

Table 9: CTC Detection Methods (Technology) Market Sales
Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: CTC Analysis (Technology) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027

Table 11: CTC Analysis (Technology) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2012 to 2019

Table 12: CTC Analysis (Technology) Market Share Distribution
in Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Cancer Stem Cell Research (Application) Demand
Potential Worldwide in US$ Million by Region/Country: 2020-2027

Table 14: Cancer Stem Cell Research (Application) Historic
Sales Analysis in US$ Million by Region/Country: 2012-2019

Table 15: Cancer Stem Cell Research (Application) Share
Breakdown Review by Region/Country: 2012 VS 2020 VS 2027

Table 16: EMT Biomarkers Development (Application) Worldwide
Latent Demand Forecasts in US$ Million by Region/Country:
2020-2027

Table 17: EMT Biomarkers Development (Application) Global
Historic Analysis in US$ Million by Region/Country: 2012-2019

Table 18: EMT Biomarkers Development (Application) Distribution
of Global Sales by Region/Country: 2012 VS 2020 VS 2027

Table 19: Tumorgenesis Research (Application) Sales Estimates
and Forecasts in US$ Million by Region/Country for the Years
2020 through 2027

Table 20: Tumorgenesis Research (Application) Analysis of
Historic Sales in US$ Million by Region/Country for the Years
2012 to 2019

Table 21: Tumorgenesis Research (Application) Global Market
Share Distribution by Region/Country for 2012, 2020, and 2027

Table 22: Other Applications (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027

Table 23: Other Applications (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019

Table 24: Other Applications (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Circulating Tumor Cell (CTC) Diagnostics Market Share (in %)
by Company: 2018 & 2025
Market Analytics
Table 25: Circulating Tumor Cell (CTC) Diagnostics Market in
US$ Million in the United States by Technology: 2020-2027

Table 26: United States Circulating Tumor Cell (CTC)
Diagnostics Market Retrospective Analysis in US$ Million by
Technology: 2012-2019

Table 27: United States Circulating Tumor Cell (CTC)
Diagnostics Market Share Breakdown by Technology: 2012 VS 2020
VS 2027

Table 28: United States Circulating Tumor Cell (CTC)
Diagnostics Latent Demand Forecasts in US$ Million by
Application: 2020 to 2027

Table 29: Circulating Tumor Cell (CTC) Diagnostics Historic
Demand Patterns in the United States by Application in US$
Million for 2012-2019

Table 30: Circulating Tumor Cell (CTC) Diagnostics Market Share
Breakdown in the United States by Application: 2012 VS 2020 VS
2027

CANADA
Table 31: Circulating Tumor Cell (CTC) Diagnostics Market
Analysis in Canada in US$ Million by Technology: 2020-2027

Table 32: Circulating Tumor Cell (CTC) Diagnostics Market in
Canada: Historic Review in US$ Million by Technology for the
Period 2012-2019

Table 33: Canadian Circulating Tumor Cell (CTC) Diagnostics
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

Table 34: Canadian Circulating Tumor Cell (CTC) Diagnostics
Market Quantitative Demand Analysis in US$ Million by
Application: 2020 to 2027

Table 35: Circulating Tumor Cell (CTC) Diagnostics Market in
Canada: Summarization of Historic Demand Patterns in US$
Million by Application for 2012-2019

Table 36: Canadian Circulating Tumor Cell (CTC) Diagnostics
Market Share Analysis by Application: 2012 VS 2020 VS 2027

JAPAN
Table 37: Japanese Medium & Long-Term Outlook for Circulating
Tumor Cell (CTC) Diagnostics Market in US$ Million by
Technology: 2020-2027

Table 38: Circulating Tumor Cell (CTC) Diagnostics Market in
Japan in US$ Million by Technology: 2012-2019

Table 39: Japanese Circulating Tumor Cell (CTC) Diagnostics
Market Percentage Share Distribution by Technology: 2012 VS
2020 VS 2027

Table 40: Japanese Demand Estimates and Forecasts for
Circulating Tumor Cell (CTC) Diagnostics in US$ Million by
Application: 2020 to 2027

Table 41: Japanese Circulating Tumor Cell (CTC) Diagnostics
Market in US$ Million by Application: 2012-2019

Table 42: Circulating Tumor Cell (CTC) Diagnostics Market Share
Shift in Japan by Application: 2012 VS 2020 VS 2027

CHINA
Table 43: Circulating Tumor Cell (CTC) Diagnostics Market
Estimates and Forecasts in China in US$ Million by Technology:
2020-2027

Table 44: Chinese Circulating Tumor Cell (CTC) Diagnostics
Retrospective Market Scenario in US$ Million by Technology:
2012-2019

Table 45: Circulating Tumor Cell (CTC) Diagnostics Market in
China: Percentage Share Analysis by Technology for 2012, 2020,
and 2027

Table 46: Chinese Demand for Circulating Tumor Cell (CTC)
Diagnostics in US$ Million by Application: 2020 to 2027

Table 47: Circulating Tumor Cell (CTC) Diagnostics Market
Review in China in US$ Million by Application: 2012-2019

Table 48: Chinese Circulating Tumor Cell (CTC) Diagnostics
Market Share Breakdown by Application: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Circulating Tumor Cell (CTC) Diagnostics Market:
Competitor Market Share Scenario (in %) for 2018 & 2025
Market Analytics
Table 49: European Circulating Tumor Cell (CTC) Diagnostics
Market Demand Scenario in US$ Million by Region/Country:
2020-2027

Table 50: Circulating Tumor Cell (CTC) Diagnostics Market in
Europe: A Historic Market Perspective in US$ Million by
Region/Country for the Period 2012-2019

Table 51: European Circulating Tumor Cell (CTC) Diagnostics
Market Share Shift by Region/Country: 2012 VS 2020 VS 2027

Table 52: European Circulating Tumor Cell (CTC) Diagnostics
Market Assessment in US$ Million by Technology: 2020-2027

Table 53: European Circulating Tumor Cell (CTC) Diagnostics
Historic Market Review in US$ Million by Technology: 2012-2019

Table 54: Circulating Tumor Cell (CTC) Diagnostics Market in
Europe: Percentage Breakdown of Salesby Technology for 2012,
2020, and 2027

Table 55: European Circulating Tumor Cell (CTC) Diagnostics
Addressable Market Opportunity in US$ Million by Application:
2020-2027

Table 56: Circulating Tumor Cell (CTC) Diagnostics Market in
Europe: Summarization of Historic Demand in US$ Million by
Application for the Period 2012-2019

Table 57: European Circulating Tumor Cell (CTC) Diagnostics
Market Share Analysis by Application: 2012 VS 2020 VS 2027

FRANCE
Table 58: French Circulating Tumor Cell (CTC) Diagnostics
Market Estimates and Projections in US$ Million by Technology:
2020-2027

Table 59: French Circulating Tumor Cell (CTC) Diagnostics
Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 60: French Circulating Tumor Cell (CTC) Diagnostics
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

Table 61: Circulating Tumor Cell (CTC) Diagnostics Quantitative
Demand Analysis in France in US$ Million by Application:
2020-2027

Table 62: French Circulating Tumor Cell (CTC) Diagnostics
Historic Market Review in US$ Million by Application: 2012-2019

Table 63: French Circulating Tumor Cell (CTC) Diagnostics
Market Share Analysis: A 17-Year Perspective by Application for
2012, 2020, and 2027

GERMANY
Table 64: German Circulating Tumor Cell (CTC) Diagnostics
Latent Demand Forecasts in US$ Million by Technology: 2020-2027

Table 65: Circulating Tumor Cell (CTC) Diagnostics Market in
Germany: A Historic Perspective by Technology in US$ Million
for the Period 2012-2019

Table 66: German Circulating Tumor Cell (CTC) Diagnostics
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

Table 67: Circulating Tumor Cell (CTC) Diagnostics Market in
Germany: Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 68: German Circulating Tumor Cell (CTC) Diagnostics
Market in Retrospect in US$ Million by Application: 2012-2019

Table 69: Circulating Tumor Cell (CTC) Diagnostics Market Share
Distribution in Germany by Application: 2012 VS 2020 VS 2027

ITALY
Table 70: Circulating Tumor Cell (CTC) Diagnostics Market
Estimates and Forecasts in Italy in US$ Million by Technology:
2020-2027

Table 71: Italian Circulating Tumor Cell (CTC) Diagnostics
Retrospective Market Scenario in US$ Million by Technology:
2012-2019

Table 72: Circulating Tumor Cell (CTC) Diagnostics Market in
Italy: Percentage Share Analysis by Technology for 2012, 2020,
and 2027

Table 73: Italian Demand for Circulating Tumor Cell (CTC)
Diagnostics in US$ Million by Application: 2020 to 2027

Table 74: Circulating Tumor Cell (CTC) Diagnostics Market
Review in Italy in US$ Million by Application: 2012-2019

Table 75: Italian Circulating Tumor Cell (CTC) Diagnostics
Market Share Breakdown by Application: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 76: United Kingdom Medium & Long-Term Outlook for
Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million
by Technology: 2020-2027

Table 77: Circulating Tumor Cell (CTC) Diagnostics Market in
the United Kingdom in US$ Million by Technology: 2012-2019

Table 78: United Kingdom Circulating Tumor Cell (CTC)
Diagnostics Market Percentage Share Distribution by Technology:
2012 VS 2020 VS 2027

Table 79: United Kingdom Demand Estimates and Forecasts for
Circulating Tumor Cell (CTC) Diagnostics in US$ Million by
Application: 2020 to 2027

Table 80: United Kingdom Circulating Tumor Cell (CTC)
Diagnostics Market in US$ Million by Application: 2012-2019

Table 81: Circulating Tumor Cell (CTC) Diagnostics Market Share
Shift in the United Kingdom by Application: 2012 VS 2020 VS
2027

REST OF EUROPE
Table 82: Rest of Europe Circulating Tumor Cell (CTC)
Diagnostics Market Assessment in US$ Million by Technology:
2020-2027

Table 83: Rest of Europe Circulating Tumor Cell (CTC)
Diagnostics Historic Market Review in US$ Million by
Technology: 2012-2019

Table 84: Circulating Tumor Cell (CTC) Diagnostics Market in
Rest of Europe: Percentage Breakdown of Sales by Technology for
2012, 2020, and 2027

Table 85: Rest of Europe Circulating Tumor Cell (CTC)
Diagnostics Addressable Market Opportunity in US$ Million by
Application: 2020-2027

Table 86: Circulating Tumor Cell (CTC) Diagnostics Market in
Rest of Europe: Summarization of Historic Demand in US$ Million
by Application for the Period 2012-2019

Table 87: Rest of Europe Circulating Tumor Cell (CTC)
Diagnostics Market Share Analysis by Application: 2012 VS 2020
VS 2027

ASIA-PACIFIC
Table 88: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics
Market Estimates and Projections in US$ Million by Technology:
2020-2027

Table 89: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics
Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 90: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics
Historic Market Analysis in US$ Million by Technology: 2012 VS
2020 VS 2027

Table 91: Circulating Tumor Cell (CTC) Diagnostics Quantitative
Demand Analysis in Asia-Pacific in US$ Million by Application:
2020-2027

Table 92: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics
Historic Market Review in US$ Million by Application: 2012-2019

Table 93: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics
Market Share Analysis: A 17-Year Perspectiveby Application for
2012, 2020, and 2027

REST OF WORLD
Table 94: Circulating Tumor Cell (CTC) Diagnostics Market
Analysis in Rest of World in US$ Million by Technology:
2020-2027

Table 95: Circulating Tumor Cell (CTC) Diagnostics Market in
Rest of World: Historic Review in US$ Million by Technology for
the Period 2012-2019

Table 96: Rest of World Circulating Tumor Cell (CTC)
Diagnostics Market Share Breakdown by Technology: 2012 VS 2020
VS 2027

Table 97: Rest of World Circulating Tumor Cell (CTC)
Diagnostics Market Quantitative Demand Analysis in US$ Million
by Application: 2020 to 2027

Table 98: Circulating Tumor Cell (CTC) Diagnostics Market in
Rest of World: Summarization of Historic Demand Patterns in US$
Million by Application for 2012-2019

Table 99: Rest of World Circulating Tumor Cell (CTC)
Diagnostics Market Share Analysis by Application: 2012 VS 2020
VS 2027

IV. COMPETITION
Total Companies Profiled: 48
Read the full report: https://www.reportlinker.com/p04778754/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001